Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Women's Health

Endometrial Cancer

Endometrial carcinoma is the most common female genital tract neoplasm in the United States.
CME credit is no longer available for this conference.

Course Authors

Yevgeniya Ioffe, M.D., and Israel Zighelboim, M.D.

Dr. Ioffe is Clinical Fellow, Division of Gynecologic Oncology, and Dr. Zighelboim is Assistant Professor, Division of Gynecologic Oncology, Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO.

Within the past 12 months, Drs. Ioffe and Zighelboim report no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.

Release Date: 10/10/2011

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss the clinical presentation and disease characteristics of patients with endometrial cancer

  • Apply the epidemiology and risk factors associated with the development of endometrial cancer to their patients

  • Detail surgical and non-surgical treatment options available for the management of patients with endometrial cancer

  • List the most common cancer susceptibility syndromes associated with endometrial cancer

  • Apply information about outcome and prognosis to patients with endometrial cancer

 

TERMS AND CONDITIONS

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Sex-Related Differences in Addiction

While more men use and are addicted to drugs, women who become addicted progress faster through the landmark stages from initial use to dependence.
Authors: Jill B. Becker, Ph.D. and Jillian E. Hardee, Ph.D.
View Course
More

Caring for Women and Their Families: The Essential Role of Reproductive Rights

Medical professionals must manage reproductive rights in a highly politicized environment.
Authors: Nada L. Stotland, M.D., M.P.H.
View Course
More

Current and Emerging Therapies for Vulvo-vaginal Atrophy

Vulvo-vaginal atrophy in peri- and post-menopausal women is caused by declining, then deficient estrogen levels, and affects more than half of otherwise healthy women over age 60.
Authors: Nancy A. Phillips, M.D., and Gloria A. Bachmann, M.D.
View Course
More

Current Management of Endometriosis

Endometriosis remains one of the most complex pathologies faced by OBGYNs and primary care physicians.
Authors: Kenan Omurtag, M.D., and Amber R. Cooper, M.D., M.S.C.I.
View Course
More

Evaluation and Treatment of Polycystic Ovary Syndrome

Androgen Excess (AE)-PCOS Society recommended that PCOS be defined by clinical/biochemical hyperandrogenism.
Authors: Daniel A. Dumesic, M.D., Mark O. Goodarzi, M.D., Ph.D., Gregory D. Chazenbalk, Ph.D., David Geller, M.D., and David H. Abbott, Ph.D.
View Course
More

Central Nervous System-selective Estrogens: A Safe Estrogen Therapy

Prodrug approach seems to be the most likely to succeed, promising full benefits expected from CNS-selective ET/HT.
Authors: Istvan Merchenthaler, M.D., Ph.D., D.Sc. and Laszlo Prokai, Ph.D., D.Sc.
View Course
More